HRP20110035T1 - Memantin za liječenje blage-do-umjerene alzheimer-ove bolesti - Google Patents

Memantin za liječenje blage-do-umjerene alzheimer-ove bolesti Download PDF

Info

Publication number
HRP20110035T1
HRP20110035T1 HR20110035T HRP20110035T HRP20110035T1 HR P20110035 T1 HRP20110035 T1 HR P20110035T1 HR 20110035 T HR20110035 T HR 20110035T HR P20110035 T HRP20110035 T HR P20110035T HR P20110035 T1 HRP20110035 T1 HR P20110035T1
Authority
HR
Croatia
Prior art keywords
day
memantine
mild
dose
administration
Prior art date
Application number
HR20110035T
Other languages
English (en)
Croatian (hr)
Inventor
Mcdonald Scott
Gergel Ivan
St�ffler Albrecht
Moebius Hans-Joerg
Wirth Yvonne
Potkin Steven
Original Assignee
Merz Pharma Gmbh & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34798833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110035(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merz Pharma Gmbh & Co. Kgaa filed Critical Merz Pharma Gmbh & Co. Kgaa
Publication of HRP20110035T1 publication Critical patent/HRP20110035T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20110035T 2004-01-05 2005-01-05 Memantin za liječenje blage-do-umjerene alzheimer-ove bolesti HRP20110035T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53455304P 2004-01-05 2004-01-05
US54217604P 2004-02-04 2004-02-04
PCT/US2005/000145 WO2005067908A2 (fr) 2004-01-05 2005-01-05 Memantine destinee au traitement de la maladie d'alzheimer legere et legere a moderee

Publications (1)

Publication Number Publication Date
HRP20110035T1 true HRP20110035T1 (hr) 2011-02-28

Family

ID=34798833

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110035T HRP20110035T1 (hr) 2004-01-05 2005-01-05 Memantin za liječenje blage-do-umjerene alzheimer-ove bolesti

Country Status (17)

Country Link
US (2) US20060020042A1 (fr)
EP (1) EP1703902B1 (fr)
AT (1) ATE486592T1 (fr)
AU (1) AU2005204358B2 (fr)
CA (1) CA2551689A1 (fr)
CY (1) CY1111359T1 (fr)
DE (1) DE602005024511D1 (fr)
DK (1) DK1703902T3 (fr)
HR (1) HRP20110035T1 (fr)
IL (1) IL176689A0 (fr)
NZ (1) NZ548327A (fr)
PL (1) PL1703902T3 (fr)
PT (1) PT1703902E (fr)
RS (1) RS51540B (fr)
RU (1) RU2371173C2 (fr)
SI (1) SI1703902T1 (fr)
WO (1) WO2005067908A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
JP5666087B2 (ja) 2005-04-06 2015-02-12 アダマス・ファーマシューティカルズ・インコーポレーテッド Ｃｎｓ関連疾患の治療のための方法及び組成物
EP1899353A1 (fr) * 2005-06-22 2008-03-19 DeveloGen Aktiengesellschaft Thienopyrimidines pour compositions pharmaceutiques
CA2651898A1 (fr) * 2006-04-07 2007-10-18 Develogen Aktiengesellschaft Thienopyrimidines ayant une activite inhibitrice mnk1/mnk2 utilisees dans des compositions pharmaceutiques
EP1889847A1 (fr) * 2006-07-10 2008-02-20 DeveloGen Aktiengesellschaft Dérivés de pyrrolopyrimidine pour applications pharmaceutiques
CN101516401A (zh) * 2006-08-21 2009-08-26 诺瓦提斯公司 阿尔茨海默病进展的生物标记
US20080182908A1 (en) * 2007-01-25 2008-07-31 Vinita Umashankar Vyas Pharmaceutical compositions comprising memantine
EP2219649A2 (fr) * 2007-11-22 2010-08-25 Boehringer Ingelheim International Gmbh Utilisation d'inhibiteurs de mnk pour le traitement de la maladie d'alzheimer
MX2011001938A (es) 2008-08-26 2011-03-29 Boehringer Ingelheim Int Tienopirimidinas para composiciones farmaceuticas.
ES2467923T3 (es) 2009-09-30 2014-06-13 Transtech Pharma, Llc Derivados de imidazol substituidos para el tratamiento de la enfermedad de Alzheimer
UY33241A (es) * 2010-02-26 2011-09-30 Boehringer Ingelheim Int ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
EP2539343B1 (fr) * 2010-02-26 2015-12-30 Evotec International GmbH Thiénopyrimidines contenant un groupe alkyle substitué pour des compositions pharmaceutiques
UY33246A (es) * 2010-02-26 2011-09-30 Boehringer Ingelheim Int Tienopirimidinas que contienen cicloalquilo para composiciones farmacéuticas
US20140350380A1 (en) * 2011-09-19 2014-11-27 The Feinstein Institute For Medical Research Identification and uses of brain activity networks
JP5404750B2 (ja) * 2011-11-22 2014-02-05 シャープ株式会社 認知症ケア支援方法、認知症情報出力装置、認知症ケア支援システム、及びコンピュータプログラム
FR2983732B1 (fr) * 2011-12-09 2013-11-22 Servier Lab Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent
US9242009B2 (en) 2012-07-17 2016-01-26 The General Hospital Corporation Compositions and methods to treat neurodegenerative diseases
US9717710B2 (en) 2012-10-05 2017-08-01 Vtv Therapeutics Llc Treatment of mild and moderate Alzheimer's disease
EP3019865A4 (fr) * 2013-07-12 2017-04-05 Immuneering Corporation Systèmes, procédés, et environnement pour l'examen automatisé de données génomiques pour identifier une expression génétique régulée à la baisse et/ou régulée à la hausse indicative d'une maladie ou d'un état
WO2019190823A1 (fr) 2018-03-28 2019-10-03 Vtv Therapeutics Llc Sels pharmaceutiquement acceptables de [3-(4- {2-butyl-1-[4-(4-chlorophénoxy)-phényl]-1h-imidazol-4-yl} -phénoxy)-propyl]-diéthyl-amine
WO2019190822A1 (fr) 2018-03-28 2019-10-03 Vtv Therapeutics Llc Formes cristallines de [3-(4- {2-butyl-1-[4-(4-chloro-phénoxy)-phényl]-1h-imidazol-4-yl} -phénoxy)-propyl]-diéthyl-amine
JP7402225B2 (ja) 2018-05-11 2023-12-20 ロード アイランド ホスピタル ヌクレオシド系逆転写酵素阻害剤を用いて関節障害を処置するための組成物および方法
JP7464591B2 (ja) 2018-10-10 2024-04-09 ブイティーブイ・セラピューティクス・エルエルシー ［３－（４－｛２－ブチル－１－［４－（４－クロロ－フェノキシ）－フェニル］－１ｈ－イミダゾール－４－イル｝－フェノキシ）－プロピル］－ジエチル－アミンの代謝産物
SG11202107145SA (en) 2019-01-25 2021-08-30 Univ Brown Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders
US20210002650A1 (en) * 2019-07-03 2021-01-07 University Of Virginia Patent Foundation Compositions and methods for treating alzheimer's disease
KR102271305B1 (ko) * 2020-05-21 2021-06-30 주식회사 아리바이오 치매 예방 및 치료용 조성물
WO2022025785A1 (fr) 2020-07-29 2022-02-03 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Composition pharmaceutique comprenant de la mémantine et de la citicoline
KR102272907B1 (ko) * 2020-11-05 2021-07-05 주식회사 아리바이오 치매 예방 및 치료용 조성물
EP4543454A1 (fr) * 2022-06-24 2025-04-30 Aribio Co., Ltd Compositions et méthodes de prévention et de traitement de maladies neurodégénératives
EP4547254A1 (fr) * 2022-06-29 2025-05-07 Aribio Co., Ltd Composition visant à prévenir et à traiter les maladies neurodégénératives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES413944A1 (es) * 1972-04-20 1976-06-01 Merz & Co Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5.
DE2856393C2 (de) * 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
US5334618A (en) * 1991-04-04 1994-08-02 The Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US5506231A (en) * 1989-03-31 1996-04-09 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy and blindness
DE58905637D1 (de) * 1989-04-14 1993-10-21 Merz & Co Gmbh & Co Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie.
US5614560A (en) * 1991-04-04 1997-03-25 Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US5958919A (en) * 1996-09-20 1999-09-28 Washington University Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
UA61962C2 (uk) * 1997-06-30 2003-12-15 Мерц Фарма Гмбх Унд Ко. Кгаа Сполука 1-аміноалкілциклогексану, фармацевтична композиція на її основі та спосіб лікування
GB9806513D0 (en) * 1998-03-26 1998-05-27 Phytopharm Ltd Membrane-bound receptors
US20040102525A1 (en) * 2002-05-22 2004-05-27 Kozachuk Walter E. Compositions and methods of treating neurological disease and providing neuroprotection
WO2003101458A1 (fr) * 2002-05-31 2003-12-11 H. Lundbeck A/S Combinaison d'un antagoniste de n-methyl d-aspartate et d'inhibiteurs de l'esterase d'acetylcholine pour le traitement de la maladie d'alzheimer
KR100777904B1 (ko) * 2002-10-24 2007-11-28 메르츠 파마 게엠베하 운트 코. 카가아 1-아미노시클로헥산 유도체 및 아세틸콜린에스테라제 저해제를 포함하는 약학적 제품 및 이를 이용한 복합 치료
WO2004071431A2 (fr) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Composition et methode de traitement de troubles neurodegeneratifs

Also Published As

Publication number Publication date
EP1703902A2 (fr) 2006-09-27
US20100048726A1 (en) 2010-02-25
SI1703902T1 (sl) 2011-02-28
IL176689A0 (en) 2006-10-31
DE602005024511D1 (de) 2010-12-16
ATE486592T1 (de) 2010-11-15
WO2005067908A3 (fr) 2005-11-10
PL1703902T3 (pl) 2011-04-29
EP1703902B1 (fr) 2010-11-03
DK1703902T3 (da) 2011-02-14
NZ548327A (en) 2009-06-26
AU2005204358B2 (en) 2008-09-04
CA2551689A1 (fr) 2005-07-28
AU2005204358A1 (en) 2005-07-28
US20060020042A1 (en) 2006-01-26
WO2005067908A2 (fr) 2005-07-28
RU2371173C2 (ru) 2009-10-27
PT1703902E (pt) 2010-11-17
RU2007129842A (ru) 2009-02-10
RS51540B (sr) 2011-06-30
CY1111359T1 (el) 2015-08-05

Similar Documents

Publication Publication Date Title
HRP20110035T1 (hr) Memantin za liječenje blage-do-umjerene alzheimer-ove bolesti
CA2883751A1 (fr) Procedes de traitement de la maladie d'alzheimer et compositions pharmaceutiques associees
BR0316753A (pt) Método de tratamento para disfunção sexual
MX2020012180A (es) Compuestos biciclicos fusionados utiles como inhibidores de la peptidasa 30 especifica de ubiquitina.
BRPI0507966A (pt) uso de meloxicam para o tratamento de doenças respiratórias em porcos
CA2492081A1 (fr) Compositions pharmaceutiques comprenant du dextromethorphan et de la quinidine pour traiter des troubles neurologiques
CO6150188A2 (es) Uso de teencteplasa para tratar un ictus isquemico agudo
RU2008116931A (ru) Применение n-десметилклозапина для лечения нейропсихиатрических заболеваний у людей
BRPI0411451A (pt) formas de dosagens orais de memantina
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
MX354423B (es) Formulaciones de rasagilina de liberación prolongada y usos de las mismas.
CA2503810A1 (fr) Agent therapeutique de la fibromyalgie
ATE469880T1 (de) Acyloxyalkylcarbamat-prodrugs von tranexansäure und anwendung
ATE438383T1 (de) Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen
MX2023001014A (es) Composiciones farmaceuticas que comprenden venglustat.
AR030039A1 (es) Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento
RU2015122256A (ru) Композиции, содержащие вортиоксетин и донепезил
EP4700016A3 (fr) Agent pharmaceutique pour traiter la sclérose latérale amyotrophique ou supprimer la progression de la maladie de celui-ci
MXPA05011432A (es) Uso de dipiridamol o mopidamol para tratamiento y prevencion de enfermedades trombo-embolicas y desordenes originados por formacion excesiva de trombina y/o por expresion elevada de receptores de trombina.
RU2012157328A (ru) Лекарственное средство для профилактического и/или терапевтического лечения деменции по типу альцгеймера
WO2017182873A3 (fr) Composés foldamères de peptide-oligourée et leurs procédés d'utilisation
RU2008127882A (ru) Лечение пищевода барретта
JP2016505050A5 (fr)
ATE410152T1 (de) Therapeutisches system mit amoxicillin und clavulansäure
RU2012108144A (ru) Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами